Derek Meisner
2021 - X4 Pharmaceuticals
In 2021, Derek Meisner earned a total compensation of $1M as Chief Legal Officer and Corporate Secretary at X4 Pharmaceuticals, a 7% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $184,338 |
---|---|
Salary | $428,173 |
Stock Awards | $415,234 |
Other | $11,524 |
Total | $1,039,269 |
Meisner received $428.2K in salary, accounting for 41% of the total pay in 2021.
Meisner also received $184.3K in non-equity incentive plan, $415.2K in stock awards and $11.5K in other compensation.
Rankings
In 2021, Derek Meisner's compensation ranked 8,671st out of 12,415 executives tracked by ExecPay. In other words, Meisner earned more than 30.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,671 | 30th |
Manufacturing | 3,845 | 30th |
Chemicals And Allied Products | 1,697 | 28th |
Drugs | 1,510 | 28th |
Biological Products, Except Diagnostic Substances | 329 | 27th |
Meisner's colleagues
We found two more compensation records of executives who worked with Derek Meisner at X4 Pharmaceuticals in 2021.
News
Acumen Pharmaceuticals CEO Daniel O'Connell's 2023 pay jumps 48% to $3.9M
April 22, 2024
Acumen Pharmaceuticals CEO Daniel O'Connell's 2022 pay jumps 80% to $2.7M
April 27, 2023
X4 Pharmaceuticals CEO Paula Ragan's 2021 pay slips 15% to $2.1M
April 25, 2022
X4 Pharmaceuticals CEO Paula Ragan's 2020 pay rises 1% to $2.5M
April 20, 2021